Health Sciences

Penn Dental Medicine Study Produces Low-cost Drug in Lettuce

Biopharmaceuticals, or drugs that are based on whole proteins, are expensive to make and require refrigeration to store. Insulin, for example, is unaffordable and inaccessible to most of the global population.

Katherine Unger Baillie

Penn Dental Medicine Study Blocks Inflammatory Bone Loss in Gum Disease

Periodontitis, a severe form of gum disease, doesn’t just cause soft-tissue inflammation and bleeding. It also destroys the bone that supports the teeth. If it progresses unchecked, it can lead to tooth loss and is even associated with systemic inflammatory conditions like atherosclerosis and rheumatoid arthritis. 

Katherine Unger Baillie

Penn Engineers Design Color-Changing Material That Could Help Diagnose Concussions

The precise link between concussions and debilitating conditions like chronic traumatic encephalopathy is still being explored, but as the name suggests, repeated head injuries are a main culprit. Unfortunately, unlike a broken bone or a torn ligament, concussions are invisible and tricky to diagnose.

Evan Lerner

Puppies Bring Cuteness and Pedigree to Working Dog Center

The Penn Vet Working Dog Center (WDC) recently received an injection of cuteness—and talent. Five Labrador retriever puppies from the “Q litter” reported to the Center to start qualified training on Aug. 21, at exactly 8 weeks old.

Katherine Unger Baillie

Cancer Doesn't Sleep: The Myc Oncogene Disrupts Circadian Rhythm and Metabolism in Cancer Cells, Finds New Penn Study

Myc is a cancer-causing gene responsible for disrupting the normal 24-hour internal rhythm and metabolic pathways in cancer cells, found a team led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Postdoctoral fellow Brian Altman, PhD, and doctoral student Annie Hsieh, MD, both from the lab of senior author Chi Van Dang, MD, PhD, director of the Abramson Cancer Center, study body clock proteins associated with cancer cells.

Karen Kreeger

Multiple Myeloma Patients More Vulnerable to 'Financial Toxicity' Due to Expensive, Longer Courses of Treatments, Penn Study Finds

Even patients with health insurance who have multiple myeloma may be vulnerable to “financial toxicity” – including those who make over $100,000 a year – because of the higher use of novel therapeutics and extended duration of myeloma treatment, researchers from Penn’s Abramson Cancer Center report in this week’s 

Steve Graff

Penn Team Pinpoints Immune Changes in Blood of Melanoma Patients on PD-1 Drugs That Put Potential Biomarker within Reach

A simple blood test can detect early markers of “reinvigorated” T cells and track immune responses in metastatic melanoma patients after initial treatment with the anti-PD-1 drug pembrolizumab, researchers from the Abramson Cancer Center of the University of Pennsylvania report in new research being presented at the inaugural CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.

Steve Graff

Penn Study Demonstrates Genes' Major Role in Skin and Organ Development

Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood.

Karen Kreeger



In the News


6ABC.com

Bird flu suspected in deaths of 200 snow geese in Pennsylvania’s Lehigh Valley

Stephen Cole of the School of Veterinary Medicine says that indoor cats are contracting bird flu through raw pet foods of poultry origin or raw milk products.

FULL STORY →



Self

The surgeon general calls for new warning labels on alcohol—here’s the truth about how it impacts your health

Henry Kranzler of the Perelman School of Medicine says that alcohol’s effects on the brain are observed more readily because it’s the organ of behavior.

FULL STORY →



NPR

Tuberculosis rates plunge when families living in poverty get a monthly cash payout

Aaron Richterman of the Perelman School of Medicine says that there are large and underappreciated benefits of cash-transfer programs, such as potentially ending a tuberculosis epidemic.

FULL STORY →



Newsweek

Cancer breakthrough as ‘speckles’ may reveal best treatment

A paper co-authored by PIK Professor Shelley Berger finds that patterns of “speckles” in the heart of tumor cells could help predict how patients with a common form of kidney cancer will respond to treatment options.

FULL STORY →



Time

Scientists are racing to develop a new bird flu vaccine

Drew Weissman and Scott Hensley of the Perelman School of Medicine are testing a vaccine to prevent a strain of H5N1 bird flu in chickens and cattle.

FULL STORY →